arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 1/2016 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Cardiac failure: sacubitril/valsartan (ENTRESTO)

    THERAPY FROM A CRITICAL VIEWPOINT

    Anticoagulation in atrial fibrillation and advanced renal insufficiency

    a-t READER 'S QUESTIONS AND COMMENTS

    Modified-release hydrocortisone for adrenal insufficiency?

    IN BRIEF

    Chlamydia infection: doxycycline versus azithromycin

    Oral phenylephrine without benefit in common cold

    Surrogate endpoints in oncology

    CURRENT ADR NETWORK REPORT

    Anosmia with nasal sprays containing glucocorticoids
    free

    SIDE EFFECTS

    Angioedema with ACE inhibitors plus racecadotril

    Intravenous iron preparations: different risks for anaphylaxis

    Finasteride and suicidality

    e a-t IN THE INTERNET

    PCSK-9 inhibitor alirocumab (PRALUENT)

    ROCKET AF trial with rivaroxaban is reexamined

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles